down arrow

Pfizer

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,053.50
21.55 (0.53%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 10.59 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4,007.154,165.45

52 Week

3,742.906,452.85
Valuation
Technical
Day's Volume

CASH

10.59 k (-30.04%) Volume

Shareholding (Dec 2024)

FII

2.75%

Held by 88 FIIs

DII

16.79%

Held by 24 DIIs

Promoter

63.92%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 0.46% and Operating profit at 4.27% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

With ROE of 16.4, it has a Very Expensive valuation with a 4.9 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 18,544 Cr (Mid Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.87%

stock-summary
Debt Equity

-0.60

stock-summary
Return on Equity

16.41%

stock-summary
Price to Book

4.92

Revenue and Profits (1 Year):
Net Sales:
538 Cr
(Quarterly Results - Dec 2024)
Net Profit:
128 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.87%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-29.38%
0%
-29.38%
1 Year
-3.19%
0.82%
-2.37%
2 Years
11.45%
1.06%
12.51%
3 Years
-9.41%
2.49%
-6.92%
4 Years
-15.51%
2.11%
-13.4%
5 Years
-8.01%
2.87%
-5.14%

Latest dividend: 35 per share ex-dividend date: Aug-21-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.46%
EBIT Growth (5y)
4.27%
EBIT to Interest (avg)
50.67
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.79
Tax Ratio
26.21%
Dividend Payout Ratio
29.04%
Pledged Shares
0
Institutional Holding
19.54%
ROCE (avg)
46.85%
ROE (avg)
19.67%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
33
Price to Book Value
4.92
EV to EBIT
25.16
EV to EBITDA
23.07
EV to Capital Employed
10.75
EV to Sales
7.25
PEG Ratio
1.48
Dividend Yield
0.87%
ROCE (Latest)
43.00%
ROE (Latest)
16.41%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 21 Schemes (11.3%)

FIIs

Held by 88 FIIs (2.75%)

Promoter with highest holding

Pfizer East India B V (39.75%)

Highest Public shareholder

Life Insurance Corporation Of India (4.07%)

Individual Investors Holdings

12.12%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -8.60% vs 4.57% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -19.42% vs 5.07% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "537.99",
          "val2": "588.59",
          "chgp": "-8.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "145.99",
          "val2": "189.25",
          "chgp": "-22.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.51",
          "val2": "2.10",
          "chgp": "-28.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "127.60",
          "val2": "158.35",
          "chgp": "-19.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.14%",
          "val2": "32.15%",
          "chgp": "-5.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.06% vs -10.06% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 27.45% vs -29.43% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,151.45",
          "val2": "1,106.57",
          "chgp": "4.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "366.74",
          "val2": "293.32",
          "chgp": "25.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.21",
          "val2": "5.60",
          "chgp": "-24.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "309.06",
          "val2": "242.49",
          "chgp": "27.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.85%",
          "val2": "26.51%",
          "chgp": "5.34%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.61% vs -11.10% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 17.23% vs -24.64% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,689.44",
          "val2": "1,646.54",
          "chgp": "2.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "512.73",
          "val2": "445.87",
          "chgp": "15.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.72",
          "val2": "8.46",
          "chgp": "-32.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "7.95",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "436.66",
          "val2": "372.47",
          "chgp": "17.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.35%",
          "val2": "27.08%",
          "chgp": "3.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -9.55% vs -7.13% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -11.64% vs 1.86% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,193.17",
          "val2": "2,424.76",
          "chgp": "-9.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "635.30",
          "val2": "808.86",
          "chgp": "-21.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "15.41",
          "val2": "13.39",
          "chgp": "15.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.95",
          "val2": "33.00",
          "chgp": "-75.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "551.33",
          "val2": "623.93",
          "chgp": "-11.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.97%",
          "val2": "33.36%",
          "chgp": "-4.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
537.99
588.59
-8.60%
Operating Profit (PBDIT) excl Other Income
145.99
189.25
-22.86%
Interest
1.51
2.10
-28.10%
Exceptional Items
0.00
0.00
Standalone Net Profit
127.60
158.35
-19.42%
Operating Profit Margin (Excl OI)
27.14%
32.15%
-5.01%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -8.60% vs 4.57% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -19.42% vs 5.07% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,151.45
1,106.57
4.06%
Operating Profit (PBDIT) excl Other Income
366.74
293.32
25.03%
Interest
4.21
5.60
-24.82%
Exceptional Items
0.00
0.00
Standalone Net Profit
309.06
242.49
27.45%
Operating Profit Margin (Excl OI)
31.85%
26.51%
5.34%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.06% vs -10.06% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 27.45% vs -29.43% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,689.44
1,646.54
2.61%
Operating Profit (PBDIT) excl Other Income
512.73
445.87
15.00%
Interest
5.72
8.46
-32.39%
Exceptional Items
0.00
7.95
-100.00%
Standalone Net Profit
436.66
372.47
17.23%
Operating Profit Margin (Excl OI)
30.35%
27.08%
3.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 2.61% vs -11.10% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 17.23% vs -24.64% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
2,193.17
2,424.76
-9.55%
Operating Profit (PBDIT) excl Other Income
635.30
808.86
-21.46%
Interest
15.41
13.39
15.09%
Exceptional Items
7.95
33.00
-75.91%
Standalone Net Profit
551.33
623.93
-11.64%
Operating Profit Margin (Excl OI)
28.97%
33.36%
-4.39%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -9.55% vs -7.13% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -11.64% vs 1.86% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Pfizer Ltd. stock-summary
stock-summary
Pfizer Ltd.
Mid Cap
Pharmaceuticals & Drugs
Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories. It has its own manufacturing facility at Goa and Thane. It has the distinction of being the first pharmaceutical company in India to start clinical research. The Company sells products in nearly 185 countries having 43 manufacturing sites globally.
Company Coordinates stock-summary
Company Details
The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E Mumbai Maharashtra : 400051
stock-summary
Tel: 91-22-66932000
stock-summary
http://www.pfizerindia.com
stock-summary
contactus.india@pfizer.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."